| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
43,396 |
34,313 |
$7.60M |
| X4011 |
State-specific procedure code |
18,676 |
17,613 |
$3.79M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,632 |
13,692 |
$2.51M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,794 |
11,683 |
$1.71M |
| Y7506 |
|
11,974 |
10,221 |
$1.33M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,411 |
26,229 |
$1.32M |
| 80053 |
Comprehensive metabolic panel |
24,737 |
23,193 |
$1.17M |
| 81001 |
|
2,369 |
2,202 |
$282K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,836 |
5,485 |
$254K |
| X4006 |
|
370 |
274 |
$191K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,568 |
1,513 |
$161K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,002 |
205 |
$149K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
976 |
797 |
$142K |
| 64483 |
|
333 |
327 |
$139K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,251 |
1,233 |
$107K |
| 64493 |
|
239 |
189 |
$106K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
268 |
265 |
$76K |
| 84703 |
|
254 |
244 |
$66K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,902 |
1,806 |
$63K |
| X4003 |
|
1,117 |
943 |
$59K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
642 |
636 |
$57K |
| 71046 |
Radiologic examination, chest; 2 views |
554 |
527 |
$49K |
| 36415 |
Collection of venous blood by venipuncture |
1,095 |
962 |
$48K |
| 64635 |
|
44 |
41 |
$47K |
| 83690 |
|
392 |
360 |
$43K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
595 |
578 |
$36K |
| G0378 |
Hospital observation service, per hour |
199 |
153 |
$35K |
| 84484 |
|
1,439 |
1,199 |
$33K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
104 |
103 |
$32K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
145 |
140 |
$28K |
| 71045 |
Radiologic examination, chest; single view |
530 |
495 |
$26K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
296 |
266 |
$26K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
623 |
540 |
$25K |
| 87070 |
|
271 |
267 |
$24K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
229 |
224 |
$19K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
94 |
82 |
$19K |
| 43275 |
|
12 |
12 |
$19K |
| Y7507 |
|
281 |
200 |
$17K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
388 |
371 |
$16K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
308 |
302 |
$15K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
106 |
98 |
$15K |
| 90870 |
|
47 |
13 |
$14K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
40 |
40 |
$13K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
273 |
252 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
151 |
135 |
$10K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
627 |
557 |
$10K |
| 80061 |
Lipid panel |
330 |
321 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
49 |
39 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
111 |
110 |
$7K |
| J3490 |
Unclassified drugs |
2,642 |
1,500 |
$6K |
| 92587 |
|
63 |
62 |
$5K |
| 92567 |
|
159 |
156 |
$4K |
| 84144 |
|
79 |
75 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
70 |
58 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
77 |
66 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12 |
12 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
122 |
121 |
$2K |
| 84702 |
|
24 |
24 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25 |
25 |
$2K |
| 93017 |
|
13 |
13 |
$2K |
| 85652 |
|
92 |
91 |
$2K |
| 97597 |
|
36 |
27 |
$2K |
| 86140 |
|
78 |
78 |
$2K |
| 20610 |
|
14 |
12 |
$2K |
| 93798 |
|
78 |
12 |
$2K |
| 80081 |
|
12 |
12 |
$2K |
| 86850 |
|
12 |
12 |
$1K |
| 86900 |
|
12 |
12 |
$1K |
| 86901 |
|
12 |
12 |
$1K |
| 81002 |
|
17 |
17 |
$1K |
| 86803 |
|
12 |
12 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30 |
30 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
14 |
$1K |
| 82077 |
|
82 |
77 |
$1K |
| 85027 |
|
122 |
120 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$1K |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
29 |
12 |
$656.05 |
| 88342 |
|
12 |
12 |
$572.97 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
27 |
16 |
$394.82 |
| 80076 |
|
55 |
52 |
$263.00 |
| 82043 |
|
12 |
12 |
$200.67 |
| 82570 |
|
12 |
12 |
$199.23 |
| 83605 |
|
72 |
58 |
$164.52 |
| 82803 |
|
56 |
48 |
$156.50 |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
12 |
12 |
$153.72 |
| 36591 |
|
90 |
53 |
$150.34 |
| 82962 |
|
154 |
107 |
$93.68 |
| 82330 |
|
26 |
24 |
$73.77 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,012 |
807 |
$72.25 |
| 85610 |
|
74 |
60 |
$65.80 |
| 76937 |
|
13 |
12 |
$41.42 |
| 83735 |
|
12 |
12 |
$24.12 |
| 82375 |
|
13 |
12 |
$20.80 |
| 83050 |
|
13 |
12 |
$13.12 |
| 85018 |
|
26 |
24 |
$12.76 |
| 87340 |
|
13 |
13 |
$8.26 |
| J2704 |
Injection, propofol, 10 mg |
52 |
37 |
$3.58 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
891 |
793 |
$0.68 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
147 |
138 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
53 |
51 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
591 |
433 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
27 |
24 |
$0.00 |
| 99152 |
|
208 |
193 |
$0.00 |
| C1757 |
Catheter, thrombectomy/embolectomy |
72 |
67 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
15 |
15 |
$0.00 |
| 81025 |
|
13 |
13 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
44 |
32 |
$0.00 |
| A4649 |
Surgical supply; miscellaneous |
26 |
13 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
383 |
340 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
91 |
81 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
30 |
24 |
$0.00 |
| C1769 |
Guide wire |
84 |
81 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
65 |
65 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
56 |
55 |
$0.00 |
| 64494 |
|
19 |
13 |
$0.00 |
| 74330 |
|
16 |
15 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
37 |
22 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
12 |
12 |
$0.00 |